Antibodies to a Full-Length VAR2CSA Immunogen Are Broadly Strain-Transcendent but Do Not Cross-Inhibit Different Placental-Type Parasite Isolates
Author Information
Author(s): Avril Marion, Hathaway Marianne J., Srivastava Anand, Dechavanne Sébastien, Hommel Mirja, Beeson James G., Smith Joseph D., Gamain Benoît
Primary Institution: Seattle Biomedical Research Institute
Hypothesis
Does immunization with full-length VAR2CSA induce broadly cross-reactive antibodies that inhibit placental-type parasite isolates?
Conclusion
Immunization with full-length VAR2CSA recombinant protein generates strain-specific adhesion blocking antibodies but does not induce cross-inhibition of different parasite strains.
Supporting Evidence
- Immunization with both immunogens induced antibodies reacting with several VAR2CSA individual domains.
- Antibodies that inhibited adhesion of parasites to CSA were only elicited in rabbits immunized with the full-length immunogen.
- Partial and full-length VAR2CSA immunogens induced cross-reactive antibodies, but inhibitory responses were highly allele-specific.
Takeaway
The study shows that a full-length malaria vaccine candidate can make antibodies that work against many types of malaria, but these antibodies only stop the specific type of malaria they were made for.
Methodology
Mice and rabbits were immunized with either a partial length or a full-length VAR2CSA recombinant protein, and antibody responses were assessed using ELISA and adhesion inhibition assays.
Limitations
The study primarily involved animal models, and the results may not directly translate to human responses.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website